Completed PHASE3 INTERVENTIONAL 2-arm NCT01698320

Safety Study of Albuterol Spiromax® in Subjects With Asthma

A Multi-Center 52-Week Study to Assess the Safety of Albuterol Spiromax® in Subjects With Asthma

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Conditions Asthma

Interventions Albuterol MDPI Placebo MDPI

Updated 8 times since 2017 Last updated: Aug 12, 2015 Started: Oct 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01698320, this PHASE3 trial focuses on Asthma and remains completed. Sponsored by Teva Branded Pharmaceutical Products R&D, Inc., it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jan 2022 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Teva Branded Pharmaceutical Products R&D, Inc.

Data source: Teva Branded Pharmaceutical Products R&D, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bellevue, United States , Bethesda, United States , Burke, United States , Canton, United States , Cincinnati, United States , Denver, United States , El Paso, United States , Eugene, United States , Gainesville, United States , Greenfield, United States and 17 more locations